I. Introduction
Type 2 diabetes mellitus is characterized by insulin resistance, which may be combined with relative insulin secretion. The defective responsiveness of the body tissues to insulin is believed to involve the insulin receptor. However, the specific defects are not well understood. Type 2 diabetes is the most common. In the early stage of type 2, the prominent abnormality is reduced insulin sensitivity. At this stage, hyperglycemia can be reversed by variety of measures and medications that improves insulin sensitivity or reduce glucose production by the liver [1] Minerals are structural components of body tissues as well as involved in various processes like cofactor of several enzymes. They also play an important role in energy production [2] . Zinc is an essential trace element that is directly involved in the synthesis, storage and secretion of insulin, as well as conformational integrity of insulin. Zinc is also required for normal immune function, taste acuity and enhances the in vitro effectiveness of insulin. The function of zinc in the body metabolism is based on its enzymatic affinity and way of a zinc-enzyme complex or metallo-enzyme. Zinc is required for insulin synthesis and storage and insulin is secreted as zinc crystals. It maintains the structural integrity of insulin [3] . Zinc has an important role in modulating the immune system and its dysfunction in diabetes mellitus may be related in part to the status of zinc [4] .
Magnesium plays an essential physiological role in many functions of the body. It may play a role in glucose homeostasis, insulin action in peripheral tissues, and pancreatic insulin secretion [5, 6] , although the exact mechanisms are not well understood. First, magnesium functions as a cofactor for several enzymes critical for glucose metabolism utilizing high energy phosphate bonds [5] . Diminished levels of magnesium were observed to decrease tyrosine kinase activity at insulin receptors [7] and to increase intracellular calcium levels [6] leading to an impairment in insulin signaling. Thus, intracellular magnesium levels have been hypothesized to be important for maintaining insulin sensitivity in skeletal muscle or adipose tissue [8, 6] . Additionally, intracellular magnesium levels may also influence glucose-stimulated insulin secretion in pancreatic β-cells through altered cellular ion metabolism [6] oxidative stress [9] , endothelial function, and the pro inflammatory response [10, 11] .
Diabetes mellitus is associated with diverse clinical conditions; clinical assessment is focused on keeping blood glucose as close to as normal as possible. Disturbances in trace element status and increased oxidative stress in diabetes may contribute to insulin resistance and the development of diabetes and diabetic complications [12, 13] . It is in view of this that this study is intended to determine the status of serum zinc and magnesium level in diabetes mellitus for management.
II. Materials and Methods
A total of 150 subjects were recruited for the study. This consisted of 100 known type 2 diabetic subjects attending endocrinology Clinic of University of Maiduguri Teaching Hospital (UMTH), and 50 non diabetic subjects as controls.
Subjects clinically not diagnosed of type 2 diabetes mellitus were excluded from the study; type 1 diabetic subjects were also excluded from the study.
Informed consent was sought from the subjects on willingness to participate in the study. Ethical approval was obtained from the ethical committee of UMTH, in accordance with the Helsinki declaration. Five milliliter (5ml) of blood was collected from the left or right superficial veins of the antecubital region. The blood was drawn using the vacutainer syringe, 2ml of the blood was taken into fluoride oxalate container for fasting plasma glucose immediately and the remaining 3ml was dispensed into the vacutainer plain bottle, and allowed to clot at room temperature. It was centrifuged at 4000 revolution per minute (rpm) for 10mins. The serum was collected and transferred into storage cryovials, labeled and stored frozen at 4 0 c until the time for analysis. Fasting plasma glucose (FPG) concentrations were measured using glucose oxidase peroxidase method by Trinder [14] . The reagent diagnostic kit was obtained from Randox Laboratories limited. Serum magnesium was measured colorimetrically using Xylidyl Blue [15] . Serum zinc was measured colorimetrically with2-(5-Bromo-2-pyridylazo)-5-(N-propyl-N-sulfopropylamino-) phenol [16] . The data obtained were analyzed using the statistical package for social sciences (SPSS) version 16.0 for windows. Student's t' test was used to compare the means of fasting plasma glucose, serum zinc and magnesium of subjects with type 2 diabetes mellitus and the controls; Pearson's linear coefficient was used to determine the correlation between fasting plasma glucose, serum zinc and magnesium of diabetic subjects. Microsoft Excel was used to plot the correlation graph. A p-value of equal to or less than 0.05 (p≤0.05) was considered as statistically significant.
III. Results
A total of one hundred and thirty (130) subjects were recruited for the study. Table 1 shows the frequency distribution according to sex for diabetic and control subjects, of which eighty (80) (61.5%) were type 2 diabetic subjects and (50) (38.5%) were non diabetic subjects. From the (80) diabetic subjects, (30) (37.5%) were males and (50) (62.5%) were females. For the controls, 34 (68.0%) were males and 16 (32%) were females. The mean systolic BP was significantly higher (p<0.05) in type 2 diabetic subjects as compared to the controls, while there is no significance difference in the mean age, diastolic BP and BMI in type 2 diabetics when compared to the controls (table 2). The means of serum zinc and FPG were significantly (p<0.05) higher in diabetic subjects as compared to the controls. There was no significant difference (p>0.05) in the mean serum magnesium of diabetics as compared to the controls (table 3) . As presented in table 4, the negative correlation observed between serum zinc and FPG, serum magnesium and FPG were not significant (p>0.05). The correlation plots are shown in figures 1 and 2 respectively. Table 4 : Correlation between serum zinc, magnesium and FPG in diabetic subjects. 
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IV. Discussion
Diabetes mellitus, one of the commonest diseases of the mankind is linked with alteration in mineral metabolism. The serum levels of zinc and magnesium in type 2 diabetics and controls were determined in this study and related to fasting plasma glucose (FPG) and age.
In our study, it was observed that mean serum zinc level was found to be significantly higher in type 2 diabetics as compared to the control group. The effect of zinc on insulin secretion is biphasic, that is very high or very low zinc plasma concentrations impair insulin secretion [17] [18] [19] . Our finding concurs with that of Mateo et al., Ocon et al., and Osman et al., [20] [21] [22] . The increase in zinc levels in diabetics could be explained by the finding that oxidative stress in diabetics could lead to destruction of ß-cells, leading to release of high amounts of zinc from the cells into blood stream [23, 24] . The increase of plasma zinc can also reflect a deficient storage or a chronic hyper secretion of insulin in hyperglycemic patients [20] . These findings do not concur with that of Saha-roy et al., [25] . In their study, there was significantly low level of serum zinc in diabetics as compared to controls. Same study were carried out by Nsonwu et al. [26] , Chausmer et al. [3] , Naila et al. [27] and Alena et al. [28] and serum zinc was found to be significantly lower in diabetic group. In our study, there was no significant difference in the means of serum magnesium in type 2 diabetics as compared to controls. This finding agreed with that of Walter et al. [29] and Naila et al. [27] , who also reported that there were no significant differences in the means of magnesium of diabetic and the control subjects. In contrast to this study, Tripathy et al. [30] and Diwan et al. [31] reported that serum levels of magnesium were significantly lower in diabetic patients when compared with the control group. In our study, no significant correlation was observed between serum Zinc with FPG and age; Magnesium and FPG. This study was similar to that of Naila et al. [27] . However, a positive and significant correlation was observed between magnesium and age. The complications of diabetes may be mediated at least in part through oxidative stress, and zinc plays a key role in the cellular anti-oxidative defense [3] . Hence, it has been suggested that an abnormal zinc metabolism may play a role in the pathogenesis of diabetes and some of its complications [32] .
V. Conclusion
In conclusion, Zinc was found to be higher in diabetics as compared to the control group, while magnesium shows no significant difference between the diabetics and the controls.
